Ashfield acquires Sellxpert as part of DACH growth strategy

Sellxpert provides innovative sales and marketing services to national and international healthcare and pharmaceutical companies across Germany and Switzerland, complimenting Ashfield’s existing services in the DACH region. The acquisition significantly strengthens Ashfield’s presence and capabilities in Germany the largest healthcare market in Europe, and will accelerate growth into the DACH region. The acquisition is subject to approval by the competition authorities. Commenting on the announcement, Benjamin Rapp, Managing Director of Ashfield DACH said: “The acquisition of Sellxpert will strengthen Ashfield Commercial and Clinical’s presence and capabilities in Germany and place Ashfield in an excellent position in providing commercial and clinical CSO services in the DACH region. The acquisition of a 50% stake in Sellxpert Switzerland, will also provide us with a stronger presence in Switzerland with 30 employees.” “The acquisition of Sellxpert will enable further growth in Germany and internationally and strengthen our existing service portfolio,” said Nigel Mansford, Head of EU & CANADA for Ashfield Commercial and Medical Services. “Sellxpert offers an attractive portfolio, operational excellence, access to key customers and attractiveness for employees and applicants. Sellxpert has an excellent management team and great employees and we look forward to working together to grow the business further. ” “We are delighted that Se...
Source: Ashfield Healthcare News - Category: Pharmaceuticals Authors: Tags: Ashfield Source Type: news